PubRank

L Grunebaum

Author PubWeight™ 27.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology 1999 2.66
2 Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest 1984 2.07
3 Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. N Engl J Med 1985 1.67
4 Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci 1994 1.47
5 [Acrosyndromes induced by bleomycin in HIV 1 related Kaposi's disease. 5 cases]. Presse Med 1997 1.39
6 Arterial thrombosis and protein S deficiency. Thromb Haemost 1989 1.13
7 Circulating procoagulant microparticles in obesity. Diabetes Metab 2006 0.97
8 [Influence of protein S deficiency on the arterial thrombosis risk]. Presse Med 1991 0.92
9 Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 1995 0.92
10 A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B. Blood 1986 0.90
11 Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 1988 0.86
12 Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes (Lond) 2011 0.85
13 [The significance of circulating microparticles in physiology, inflammatory and thrombotic diseases]. Rev Med Interne 2005 0.84
14 Significance of diminished factor XIII in Crohn's disease. Am J Gastroenterol 1998 0.81
15 [Von Willebrand factor in coronary disease]. Arch Mal Coeur Vaiss 1994 0.81
16 Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis. Thromb Res 1990 0.81
17 Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides. Biochem J 1989 0.80
18 [Gray platelet syndrome]. Arch Fr Pediatr 1993 0.80
19 A deletion located in the 3' non translated part of the factor IX gene responsible for mild haemophilia B. Thromb Haemost 1993 0.79
20 [Serum cardiolipin antibodies in patients with alcoholic cirrhosis]. Gastroenterol Clin Biol 1996 0.79
21 [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation]. Ann Cardiol Angeiol (Paris) 2007 0.78
22 Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature. Haemophilia 2001 0.78
23 Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin. Br J Haematol 1991 0.77
24 [Comparative thrombotic risk of two contrast agents in coronary angiography]. Ann Radiol (Paris) 1994 0.77
25 Carrier detection in hemophilia using pedigree analysis coagulation tests and DNA probes. Nouv Rev Fr Hematol 1989 0.77
26 [Value of left atrial dilation in the diagnosis of silent myocardial ischemia in diabetes mellitus patients]. Ann Cardiol Angeiol (Paris) 2008 0.76
27 Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages. Ann Hematol 1992 0.76
28 The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma. Blood Coagul Fibrinolysis 1991 0.75
29 [Effect of E coli or Erwinia asparaginase and corticotherapy on fibrinogen concentration in induction of acute lymphoblastic leukemia in children]. Arch Pediatr 1994 0.75
30 [Variations of plasma Willebrand factor and fibrinogen in coronary pathology]. Ann Biol Clin (Paris) 1992 0.75
31 Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcome. Haemophilia 2012 0.75
32 DNA amplification of HIV genome in hemophiliacs and in newborns from seropositive mothers. Ann Hematol 1991 0.75
33 Potential thrombogenicity of angiographic contrast agents. Thromb Res 1991 0.75
34 Anti-phospholipid auto-antibodies and thrombosis. Nouv Rev Fr Hematol 1991 0.75
35 Electrophoretic studies on molecular defects of von Willebrand factor and platelet glycoprotein IIb-IIIa with antibodies produced in egg yolk from laying hens. Haemostasis 1992 0.75
36 Variation in von Willebrand's Factor according to the treatment of acute myocardial infarction: physiopathological and clinical implications. Eur Heart J 1994 0.75
37 Potential thrombogenicity of coronary angioplasty compared with coronary angiography. Blood Coagul Fibrinolysis 1994 0.75
38 [Biological manifestations of a prethrombotic state in developmental Crohn's disease]. Gastroenterol Clin Biol 1990 0.75
39 Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates. Nouv Rev Fr Hematol 1988 0.75
40 [Variable extent of platelet responsiveness to clopidogrel inhibition: "clopidogrel resistance"?]. Ann Cardiol Angeiol (Paris) 2005 0.75
41 [Protein C: importance of its assay in pathology]. Presse Med 1988 0.75
42 The treatment of deep vein thrombosis with continuous intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study. Thromb Res 1996 0.75
43 [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis]. Arch Mal Coeur Vaiss 1989 0.75